Ohio · 136th Legislature (2025-2026) · Bill

HB 263: Cap cost sharing for prescription insulin drugs, diabetes devices

In committee Last action May 14, 2025: Referred to committee

Plain-language summary

HB 263 is a bill introduced in the Ohio House on May 13, 2025. According to its official title, it concerns: Cap cost sharing for prescription insulin drugs, diabetes devices. Primary sponsor: Munira Abdullahi (Democratic), Thomas Hall (Republican). It lists 21 additional sponsors. Most recent recorded action (May 14, 2025): Referred to committee.

Sponsors

Primary sponsors: Munira Abdullahi (Democratic); Thomas Hall (Republican). 21 co-sponsors.